AHPA on NDIs
This article was originally published in The Tan Sheet
Executive Summary
"A single NDI notification may be submitted for more than one dietary supplement that contains the NDI that is the subject of the notification," AHPA maintains in a Feb. 24 addendum to previously submitted comments. "Dietary supplements that contain up to 100 mg per serving of the NDI; that are in the form of a capsule or tablet; and that are recommended to be used by adults over the age of 18 in a manner that limits daily consumption of the NDI to not more than 1,000 mg per day for up to 6 months" is a statement that would reduce the need for redundant filings, the trade group suggests. In this vein, manufacturers, marketers and distributors who sell supplements that conform to the dose and use parameters outlined in the notifications should not have to file their own NDI submissions...